ArticlePLoS computational biology2019
Identification of pathways associated with chemosensitivity through network embedding.
Article in PLoS computational biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 19 citations in OpenAlex.
- Large-scale information retrieval and correction of noisy pharmacogenomic datasets through residual thresholded deep matrix factorization.Briefings in bioinformatics · 2025Article
- Prediction and identification of synergistic compound combinations against pancreatic cancer cells.iScience · 2021Article
- Topological network measures for drug repositioning.Briefings in bioinformatics · 2021Article
- A Graph Gaussian Embedding Method for Predicting Alzheimer's Disease Progression With MEG Brain Networks.IEEE transactions on bio-medical engineering · 2021Article
- Survey on graph embeddings and their applications to machine learning problems on graphs.PeerJ. Computer science · 2021Article
- Predicting Anticancer Drug Response With Deep Learning Constrained by Signaling Pathways.Frontiers in bioinformatics · 2021Article
- Identifying Drug Sensitivity Subnetworks with NETPHIX.iScience · 2020Article
- Gaussian Embedding for Large-scale Gene Set Analysis.Nature machine intelligence · 2020Article
- Enhancing reproducibility of gene expression analysis with known protein functional relationships: The concept of well-associated protein.PLoS computational biology · 2020Article
- pathDIP 4: an extended pathway annotations and enrichment analysis resource for human, model organisms and domesticated species.Nucleic acids research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Basal gene expression levels have been shown to be predictive of cellular response to cytotoxic treatments. However, such analyses do not fully reveal complex genotype- phenotype relationships, which are partly encoded in highly interconnected molecular networks. Biological pathways provide a complementary way of understanding drug response variation among individuals. In this study, we integrate chemosensitivity data from a large-scale pharmacogenomics study with basal gene expression data from the CCLE project and prior knowledge of molecular networks to identify specific pathways mediating chemical response. We first develop a computational method called PACER, which ranks pathways for enrichment in a given set of genes using a novel network embedding method. It examines a molecular network that encodes known gene-gene as well as gene-pathway relationships, and determines a vector representation of each gene and pathway in the same low-dimensional vector space. The relevance of a pathway to the given gene set is then captured by the similarity between the pathway vector and gene vectors. To apply this approach to chemosensitivity data, we identify genes whose basal expression levels in a panel of cell lines are correlated with cytotoxic response to a compound, and then rank pathways for relevance to these response-correlated genes using PACER. Extensive evaluation of this approach on benchmarks constructed from databases of compound target genes and large collections of drug response signatures demonstrates its advantages in identifying compound-pathway associations compared to existing statistical methods of pathway enrichment analysis. The associations identified by PACER can serve as testable hypotheses on chemosensitivity pathways and help further study the mechanisms of action of specific cytotoxic drugs. More broadly, PACER represents a novel technique of identifying enriched properties of any gene set of interest while also taking into account networks of known gene-gene relationships and interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.